Genome-wide case/control studies in hypertension: Only the 'tip of the iceberg'

Journal of Hypertension

Volumn 28, Issue 6, 2010, Pages 1115-1123

  Zhang, Kuixing ^a   Weder, Alan B ^c   Eskin, Eleazar ^d   O'Connor, Daniel T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Association; Genomics; Hypertension

Indexed keywords

BODY MASS; CHROMOSOME 12Q; DIASTOLIC BLOOD PRESSURE; EPISTASIS; ESSENTIAL HYPERTENSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 77952553812     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328337f6bc     Document Type: Review

References (68)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171.
2. KupperN,Ge D,Treiber FA, Snieder H. Emergence ofnovel genetic effects on blood pressure and hemodynamics in adolescence: the Georgia Cardiovascular Twin study. Hypertension 2006; 47:948-954.
3. Mayeux R. Mapping the new frontier: complex genetic disorders. J Clin Invest 2005; 115:1404-1407.
4. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
5. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516-1517.
6. Jones HB. The relative power of linkage and association studies for the detection of genes involved in hypertension. Kidney Int 1998; 53:1446-1448.
7. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502-510.
8. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease-common variant (or not? Hum Mol Genet 2002; 11:2417-2423.
9. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008; 40:695-701.
10. Shih PA, O'Connor DT. Hereditary determinants of human hypertension: strategies in the setting of genetic complexity. Hypertension 2008; 51:1456-1464.
11. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008; 40:575-583.
12. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K,Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112.
13. International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-1320.
14. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9:356-369.
15. Musunuru KKS. HapMap and mapping genes for cardiovascular disease. Circ Cardiovasc Genet 2008; 1:66-71.
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
18. Ehret GB, Morrison AC, O'Connor AA, Grove ML, Baird L, Schwander K, et al. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet 2008; 16:1507-1511.
19. Hong KW, Jin HS, Cho YS, Lee JY, Lee JE, Cho NH, et al. Replication of the Wellcome Trust genome-wide association study on essential hypertension in a Korean population. Hypertens Res 2009; 32:570-574.
20. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41:666-676.
21. LevyD,LarsonMG, BenjaminEJ, Newton-ChehC,Wang TJ,Hwang SJ,etal. Framingham HeartStudy100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007; 8 (Suppl 1):S3.
22. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41:677-687.
23. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, et al. From the cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106:226-231.
24. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009; 41:527-534.
25. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5:e1000564.
26. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet 2009; 18:2288-2296.
27. Terwilliger JD, Hiekkalinna T. An utter refutation of the 'Fundamental Theorem of the HapMap'. Eur J Hum Genet 2006; 14:426-437.
28. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.
29. Preece MA. The genetic contribution to stature. Horm Res 1996; 45 (Suppl 2):56-58.
30. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41:25-34.
31. Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W, et al. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta- adrenergic pathway loci. J Hypertens 2007; 25:329-343.
32. Falconer DS, Mackay TFC. Introduction to quantitative genetics. 4th ed: Benjamin Cummings; 1996.
33. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19:149-150.
34. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008; 322:881-888.
35. Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, et al. Catecholamine release-inhibitory peptide catestatin (chromogranin A (352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 2007; 115:2271-2281.
36. Browning BL, Browning SR. Haplotypic analysis of Wellcome Trust Case Control Consortium data. Hum Genet 2008; 123:273-280.
37. Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008; 92:265-272.
38. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Maternal and social origins of hypertension. Hypertension 2007; 50:565-571.
39. Harrap SB. Blood pressure genetics: time to focus. J Am Soc Hypertens 2009; 3:231-237.
40. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592-599.
41. Ahituv N, Kavaslar N, Schackwitz W, Ustaszewska A, Martin J, Hebert S, et al. Medical sequencing at the extremes of human body mass. Am J Hum Genet 2007; 80:779-791.
42. Cohen JC, Pertsemlidis A, FahmiS, Esmail S, Vega GL, Grundy SM, Hobbs HH. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci USA 2006; 103:1810-1815.
43. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004; 305:869-872.
44. Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 2005; 37:161-165.
45. Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009; 119:70-79.
46. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461:272-276.
47. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, Song X, et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods 2007; 4:903-905.
48. Chen Y, Rao F, Rodriguez-Flores JL, Mahapatra NR, Mahata M, Wen G, et al. Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int 2008; 74:115-125.
49. Zhang K, Rao F, Rana BK, Gayen JR, Calegari F, King A, et al. Autonomic function in hypertension: role of genetic variation at the catecholamine storage vesicle protein chromogranin B (CHGB). Circ Cardiovasc Genet 2009; 2:46-56.
50. Wen G, Wessel J, Zhou W, Ehret GB, Rao F, Stridsberg M, et al. An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. Hum Mol Genet 2007; 16:1752-1764.
51. Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, et al. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 2007; 116:993-1006.
52. Chen Y, Wen G, Rao F, Zhang K, Wang L, Rodriguez-Flores JL, et al. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J Hypertens 2010; 28:76-86.
53. Wang L, Rao F, Zhang K, Mahata M, Rodriguez-Flores JL, Fung MM, et al. Neuropeptide Y(1) receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol 2009; 54:944-954.
54. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008; 9:387-402.
55. Schork NJ, Nath SK, FallinD,ChakravartiA.Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. Am J Hum Genet 2000; 67:1208-1218.
56. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 2007; 49:96-106.
57. Tenesa A, Visscher PM, Carothers AD, Knott SA. Mapping quantitative trait loci using linkage disequilibrium: marker-versus trait-based methods. Behav Genet 2005; 35:219-228.
58. O'Connor DT, Insel PA, Ziegler MG, Hook VY, Smith DW, Hamilton BA, et al. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2000; 2:16-22.
59. Schneider GM, Jacobs DW, Gevirtz RN, O'Connor DT. Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery. J Hum Hypertens 2003; 17:829-840.
60. Folkow B. Early structural changes in hypertension: pathophysiology and clinical consequences. J Cardiovasc Pharmacol 1993; 22 (Suppl 1):S1-S6.
61. Dempfle A, Scherag A, Hein R, Beckmann L, Chang-Claude J, Schafer H. Gene-environment interactions for complex traits: definitions, methodological requirements and challenges. Eur J Hum Genet 2008; 16:1164-1172.
62. Hein R, Beckmann L, Chang-Claude J. Sample size requirements for indirect association studies of gene-environment interactions (G x E). Genet Epidemiol 2008; 32:235-245.
63. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005; 161:799-805.
64. Chen Y, Rao F, Rodriguez-Flores JL, Mahata M, Fung MM, Stridsberg M, et al. Naturally occurring human genetic variation in the 3-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion. J Am Coll Cardiol 2008; 52:1468-1481.
65. Seasholtz TM, Wessel J, Rao F, Rana BK, Khandrika S, Kennedy BP, et al. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 2006; 47:937-947.
66. Fung MM, Nguyen C, Mehtani P, Salem RM, Perez B, Thomas B, et al. Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans. Circulation 2008; 117:517-525.
67. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet 2002; 3:872-882.
68. Wray NR, Coventry WL, James MR, Montgomery GW, Eaves LJ, Martin NG. Use of monozygotic twins to investigate the relationship between 5HTTLPR genotype, depression and stressful life events: an application of Item Response Theory. Novartis Found Symp 2008; 293:48-59; discussion 59-70.